tiprankstipranks
Vitrafy Life Sciences Ltd. (AU:VFY)
ASX:VFY
Australian Market
VFY
Vitrafy Life Sciences Ltd.
RESEARCH TOOLSreports
Want to see AU:VFY full AI Analyst Report?

Vitrafy Life Sciences Ltd. (VFY) Stock News & Sentiment

3 Followers
Vitrafy to Present U.S. Army Platelet Study Phase II Results in Investor Webinar
Premium
Company Announcements
Vitrafy to Present U.S. Army Platelet Study Phase II Results in Investor Webinar
4d ago
VFY
Vitrafy’s Cryopreserved Platelets Beat Quality Benchmarks in U.S. Army Study
Premium
Company Announcements
Vitrafy’s Cryopreserved Platelets Beat Quality Benchmarks in U.S. Army Study
4d ago
VFY
Vitrafy Issues Confidential Q3 FY26 Investor Presentation With Strict Disclaimers
Premium
Company Announcements
Vitrafy Issues Confidential Q3 FY26 Investor Presentation With Strict Disclaimers
28d ago
VFY
Vitrafy advances U.S. platelet program as demand for cryopreservation tech builds
Premium
Company Announcements
Vitrafy advances U.S. platelet program as demand for cryopreservation tech builds
28d ago
VFY
Vitrafy outlines limits on NWR Health Conference briefing and investor access
Premium
Company Announcements
Vitrafy outlines limits on NWR Health Conference briefing and investor access
2M ago
VFY
Vitrafy to Showcase Cryopreservation Technology at NWR Virtual Healthcare Conference
Premium
Company Announcements
Vitrafy to Showcase Cryopreservation Technology at NWR Virtual Healthcare Conference
2M ago
VFY
Vitrafy Life Sciences Issues Confidential 1H FY26 Financial Results Presentation
Premium
Company Announcements
Vitrafy Life Sciences Issues Confidential 1H FY26 Financial Results Presentation
4M ago
VFY
More AU:VFY News >

VFY News on the Web

What is Morgan's updated view on this red hot ASX healthcare stock?
The Motley Fool
Neutral
Vitrafy’s Cryopreserved Platelets Beat Quality Benchmarks in U.S. Army Study
TipRanks News
Bullish
Vitrafy to Present U.S. Army Platelet Study Phase II Results in Investor Webinar
TipRanks News
Bullish
Health Check: US military top brass warms to Aussie blood platelet freezing method
StockHead
Neutral
Vitrafy outlines limits on NWR Health Conference briefing and investor access
TipRanks News
Neutral
Health Check: The high-flying healthcare stocks that won#8217;t let you down
StockHead
Neutral
Vitrafy to Showcase Cryopreservation Technology at NWR Virtual Healthcare Conference
TipRanks News
Bullish
Ord Minnett Sticks to Their Buy Rating for Vitrafy Life Sciences Ltd. (VFY)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
AU:VFY
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:VFY’s Media Buzz Sentiment?
3 articles about AU:VFY were published this week. In an average week, 1.25 articles are published.
    What is AU:VFY’s weekly average amount of articles?
    In an average week, 1.25 articles about AU:VFY are published.
      What is AU:VFY’s News Sentiment?
      100% of articles about AU:VFY were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week